Compounds > n-(3-(aminomethyl)benzyl)acetamidine
Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Gastric Diseases

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Gastric Diseases in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Souza, MH1
Lemos, HP1
Oliveira, RB1
Cunha, FQ1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Gastric Diseases

ArticleYear
Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice.
    Gut, 2004, Volume: 53, Issue:6

    Topics: Amidines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylamines; Enzyme Inhibitors; Gastric

2004